Glenmark Pharmaceuticals has informed that it enclosed a media release titled ‘Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC)’.
The above information is a part of company’s filings submitted to BSE.